Business Wire

Merz Aesthetics Reveals Global Data on the Connection Between Confidence, Self-Affirmation and Aesthetic Treatments

Share

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the findings of its inaugural global study, Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation. The study explored the role confidence plays in daily life and overall well-being, as well as the connection between our internal selves and outward expression.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250129954824/en/

Graphic: Merz Aesthetics

As part of its Confidence to Be platform, Merz Aesthetics surveyed 15,000 adults from around the world who have had an aesthetic treatment in the past or are open to having one in the near future. The Pillars of Confidence study revealed that a global majority of study participants have a strong sense of self-confidence, with 72% agreeing with the statement, “I am confident in who I am.”

The findings of the Pillars of Confidence study also link external appearance to internal self-concept. When it comes to aesthetic treatments specifically, 73% of respondents reported saying they feel “empowered” after having an aesthetic treatment, 69% seek aesthetic treatments to reflect how they feel inside and 72% said that aesthetic treatments impact how they view themselves.

Conducted in partnership with Ipsos*, one of the largest market research and polling companies globally, the Pillars of Confidence study engaged 15,000 adults aged 21 to 75** from 15 countries. Participating regions and countries included:

  • Asia-Pacific: China, South Korea, Thailand
  • Europe, the Middle East & Africa: France, Germany, Italy, Spain, the United Kingdom and the United Arab Emirates
  • Latin America: Brazil, Colombia, Costa Rica, Mexico
  • North America: United States, Canada

“Since becoming a standalone global business nearly five years ago, Merz Aesthetics has been committed to our purpose of fueling confidence by helping people look better, feel better and live better. We believe in the importance of feeling confident and what makes you feel like the best version of yourself—however you define it,” said Bob Rhatigan, CEO, Merz Aesthetics. “Our Pillars of Confidence research shows what we anecdotally knew to be true—that aesthetic treatments appear to do more than just enhance our appearance; they can help people feel empowered and support their self-confidence journey.”

“The Pillars of Confidence data shows how aesthetic treatments enable patients to take an active role in aligning their self-perception with their outward appearance,” said Dr. Shannon Humphrey, cosmetic dermatologist, medical director at Humphrey & Beleznay Cosmetic Dermatology and clinical associate professor at the University of British Columbia. “As a physician, I see this impact every day. These insights can help us better understand and support our patients as they work toward personal empowerment, which ultimately enhances the care we provide.”

Whether it’s the things we say, the people we surround ourselves with, or our choices around aesthetic treatments, Merz Aesthetics believes that every person's journey to look, feel and live their best is unique. With a purpose to fuel confidence worldwide, Merz Aesthetics hopes that the data-backed insights of the Pillars of Confidence study will inspire meaningful conversations that enable even more people to celebrate being their authentic selves, both inside and out.

For more information on the Pillars of Confidence study and to download a full report of the findings, please visit www.merzaesthetics.com/confidence.

*Merz Aesthetics. (2025). Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation. Supported by research partner Ipsos.

**Age range in Asia-Pacific region was 21 to 65.

About Merz Aesthetics

Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics’ global headquarters is in Raleigh, N.C., USA, with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com.

© 2025 Merz North America, Inc. All rights reserved. Merz, Merz Aesthetics and the Merz Aesthetics Confidence To Be Logo are trademarks and/or registered trademarks of Merz Pharma GmbH & Co. KGaA in the U.S. and/or certain other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250129954824/en/

Contacts

Media Contact
Merz Aesthetics
Global Corporate Communications
6501 Six Forks Road, Raleigh NC 27615
919-302-3296
media@merz.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 02:00:00 EEST | Press release

The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster than the global economy, generating significant commercial opportunities as long as the mounting challenges of climate change, labour shortages and infrastructure gaps are addressed. Inbound and outbound trips increasing fast Asia is on track to become the world’s fastest-growing tourism economy, with the direct travel and tourism GDP contribution expected to exceed 7% across the region by 2034. Notably, India and China

The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 22:00:00 EEST | Press release

The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate

Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 15:59:00 EEST | Press release

Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 15:05:00 EEST | Press release

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for

Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model3.7.2025 13:02:00 EEST | Press release

The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently published in the prestigious International Journal of Molecular Sciences in a joint study conducted by Erlangen University Hospital and Berlin-based drug developer AudioCure. As there is currently no causal treatment for tinnitus, there is a high medical need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702168211/en/ In 10-20% of tinnitus cases, the noise in the ear is so severe that it significantly impairs the quality of life of those affected. (Source: AI-generated) In the current study, AC102 was administered to the middle ear of one experimental group after acoustic trauma, while a second group received a placebo. Although both groups initially showed signs of tinnitus, th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye